Clinical trial
Ex-Vivo Depletion of Myeloma Cells From Peripheral Blood Progenitor Cell Grafts
NCT00968396 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ex-Vivo Depletion of Myeloma Cells From Peripheral Blood Progenitor Cell Grafts
- Lead sponsor
- M.D. Anderson Cancer Center
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- February 28, 2013
- Completion date
- Not reported
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.